Trial Profile
A phase IIa proof-of-concept study of tetrahydrobiopterin (BH4) for the treatment of pain
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2016
Price :
$35
*
At a glance
- Drugs GTP cyclohydrolase modulators (Primary) ; Sepiapterin reductase modulators (Primary)
- Indications Pain
- Focus Proof of concept; Therapeutic Use
- 22 Jul 2016 New trial record